PTPRC and neoplasm: In this model, the fibrocyte-like cells were detected as CD45+/FSP-1+ cells, and the increased number of tumour-infiltrated CD45+/FSP-1+ cells after SU5416 treatment were confirmed by immunofluorescence (Supplementary Fig. 4e,f).